Clinical Trial Update: Study of the Efficacy and Safety of Broncho-munal®, Capsules, 7 mg for the Treatment of Acute Uncomplicated Respiratory Tract Infections [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of Broncho-munal capsules (7 mg) for acute uncomplicated respiratory tract infections has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Tract Infection
• Uncomplicated Respiratory Tract Infections

Drugs mentioned

• Broncho-munal (null)

Snippet

Sponsor: Sandoz | Conditions: Acute Uncomplicated Respiratory Tract Infections | Phase 3 | Status: COMPLETED